HERO Online Working Paper Series
From University of Oslo, Health Economics Research Programme HERO / Department of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway. Contact information at EDIRC. Bibliographic data for series maintained by Kristi Brinkmann Lenander (). Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.
- 2003:13: En økonomisk-politisk analyse av det norske legemiddelmarkedet En gjennomgang av reguleringsbestemmelser for legemiddelmarkedet med spesiell fokus på konsekvenser av innføring av ny apoteklov 3.mars 2001

- Ragnhild Røhme Fjørtoft
- 2003:12: Smoking and Health Investments: Impacts of Health Adaptation and Damage Reversibility

- Jared Carbone, Snorre Kverndokk and Ole Rogeberg
- 2003:11: Legemiddelmarkedet etter apotekreformen: Regulering, markedsstruktur og konkurranse

- Dag Morten Dalen
- 2003:10: Medical errors: Getting the incentives right

- Sverre Grepperud
- 2003:9: Productivity growth in Norwegian psychiatric outpatient clinics A panel data analysis of the period 1996-2001

- Vidar Hallsteinli, Jon Magnussen and Sverre Kittelsen
- 2003:8: Economies of scope in Norwegian hospital production - A DEA analysis

- Sverre Kittelsen and Jon Magnussen
- 2003:7: Far out or alone in the crowd: Classification of selfevaluators in DEA

- Dag Fjeld Edvardsen, Finn R. Føsund and Sverre Kittelsen
- 2003:6: VERDIEN AV LIV OG HELSE Hvor mye bør samfunnet være villig til å betale for helseforbedringer?

- Berit Bringedal, Tor Iversen and Ivar Sønbø Kristiansen
- 2003:5: Individuals' preferences for GPs Choice analysis from the establishment of a list patient system in Norway

- Hilde Lurås
- 2003:4: Child mortality in India: Exploring the community-level effect of education

- Øystein Kravdal
- 2003:3: Children, family and cancer survival in Norway

- Øystein Kravdal
- 2003:2: Pasientbehandling innenlands eller utenlands? En analyse av ressursbruk i Pasientbroen

- Grete Botten, Sverre Grepperud and Sølve Mikal Nerland
- 2003:1: The effect of patient shortage on general practitioners’ future income and list of patients

- Tor Iversen
- 2002:19: Fysioterapitjenesten i Asker og Bærum - Kvalitet, tilgjengelighet og effektivitet

- Sverre Kittelsen and Erik H. Roseng
- 2002:18: Hva betyr forskning, utdanning og reisetid for sykehusenes kostnader?

- Sverre Kittelsen, Jon Magnussen and Fredrik Niclas Piro
- 2002:17: The moral relevance of personal characteristics in setting health care priorities

- Jan Abel Olsen, Jeff Ricardson, Paul Dolan and Paul Mentzel
- 2002:16: An inquiry into the size of health charities: The case of Norwegian patient organisations

- Jan Abel Olsen and Jan Inge Eidem
- 2002:15: What is best and at what cost? Cross-national differences in the treatment of ageing-related diseases Norwegian perspective from a comparative OECD-project

- Grete Botten and Terje P. Hagen
- 2002:14: Beregning av tilgjengelighetsindeks til spesialisthelsetjenester på kommunenivå

- Gry Stine Kopperud
- 2002:13: Deductibles in Health Insurance: Pay or Pain?

- Geir Asheim, Tore Nilssen and Anne Wenche Emblem
- 2002:12: Statlige sykehus; Kan styrings-effektiviteten bedres?

- Ståle Opedal and Inger Marie Stigen
- 2002:11: Budget deficits as devices for appropriating extra funds: An investigation of sharing rules

- Sverre Grepperud
- 2002:10: Genetic testing and repulsion from chance

- Michael Hoel, Tore Nilssen, Jon Vislie and Tor Iversen
- 2002:9: The impact of accessibility on the use of specialist health care in Norway

- Tor Iversen and Gry Stine Kopperud
- 2002:8: The effect of activity-based financing on hospital efficiency: A panel data analysis of DEA efficiency scores 1992-2000

- Erik Biorn, Terje P. Hagen, Tor Iversen and Jon Magnussen
- 2002:7: Reforming decentralized integrated health care systems: Theory and the case of the Norwegian reform

- Kjeld Møller Pedersen
- 2002:6: Bruk av paneldatametoder til å belyse allmennlegers henvisningsmønster

- Hilde Lurås and Eline Aas
- 2002:5: Sykehuslegenes holdninger til kjøp av helsetjenester i utlandet

- Grete Botten, Sølve Mikal Nerland and Terje P. Hagen
- 2002:4: Redistribution at the hospital

- Anne Wenche Emblem
- 2002:3: A cancer survival model that takes sociodemographic variations in 'normal' mortality into account: comparison with other models

- Øystein Kravdal
- 2002:2: Public- and private-good values of statistical lives Results from a combined choice-experiment and contingent-valuation survey

- Jon Strand
- 2002:1: De somatiske sykehusenes interne organisering En kartlegging av 58 somatiske sykehus i Norge, 1999 og 2001

- Lars Erik Kjekshus, Sølve Mikal Nerland, Grete Botten and Terje P. Hagen
- 2001:13: Er liggetid betinget av finansieringsordninger? - En analyse av paneldata fra 63 norske somatiske sykehus i årene 1976-1999

- Sølve Mikal Nerland
- 2001:12: Errors in Survey Based Quality Evaluation Variables in Efficiency Models of Primary Care Physicians

- Sverre Kittelsen, Guri Galtung Kjæserud and Odd Jarle Kvamme
- 2001:11: A healthy lifestyle: The product of opportunities and preferences

- Hilde Lurås
- 2001:10: Allocating health care resources when people are risk averse with respect to life time

- Michael Hoel
- 2001:9: Efficient use of health care resources: The interaction between improved health and reduced health related income loss

- Michael Hoel
- 2001:8: Scale, efficiency and organization in Norwegian psychiatric outpatient clinics for children

- Vidar Hallsteinli, Sverre Kittelsen and Jon Magnussen
- 2001:7: On adaptation, life-extension possibilities and the demand for health

- Jon Gjerde, Sverre Grepperud and Snorre Kverndokk
- 2001:6: Incentive Contracts for Public Health Care Provision under Adverse Selection and Moral Hazard

- Jon Vislie
- 2001:5: Sykehusenes effektivitetsutvikling 1992-1999: Hvilke effekter ga innsatsstyrt finansiering?

- Terje P. Hagen, Tor Iversen and Jon Magnussen
- 2001:4: The Crowding-Out of Work Ethics

- Sverre Grepperud and Pål Andreas Pedersen
- 2001:3: Designing Competition in Health Care Markets

- Dag Morten Dalen, Espen Moen and Christian Riis
- 2001:2: Politicians and soft budget constraints

- Dag Morten Dalen, Espen Moen and Christian Riis
- 2001:1: Health Insurance: Treatment vs. Compensation

- Geir Asheim, Tore Nilssen and Anne Wenche Emblem
- 2000:10: Inkludering av pasienters vurderinger i en effektivitetsanalyse av norske allmen-praktikere - korrigering av feil i variable i DEA

- Guri Galtung Kjæserud
- 2000:9: Private health care as a supplement to a public health system with waiting time for treatment

- Michael Hoel and Erik Magnus Sæther
- 2000:8: Pengene eller Livet? -en studie av betalingsvillighet for livreddende helseprosjekter?

- Bjørnar Andreas Kvinge
- 2000:7: En analyse av tilgjengelighet og bruk av en laboratorieundersøkelse i primærhelsetjenesten

- Siri Fauli
- 2000:6: Sprekere eldre, rimeligere eldreomsorg? - Utgiftsbehovet i eldreomsorgen i perioden 2000-2030 under ulike forutsetninger om eldres funksjonsevne

- Grete Botten, Terje P. Hagen and Hans TH Waaler
- 2000:5: Why do people demand health?

- Snorre Kverndokk
- 2000:4: Betalingsvillighet for behandlingsgaranti -analyse av en befolkningsundersøkelse

- Gry Stine Kopperud
- 2000:3: Erfaringer med ISF og bruk av kostnadsinformasjon Intervjudata fra fire fylkeskommuner

- Ståle Opedal
- 2000:2: En bred kartlegging av sykehusenes økonomiske situasjon

- Trond Bjørnenak, Terje P. Hagen, Tor Iversen and Jon Magnussen
- 2000:1: ISF og sykehusenes effektivitet - Erfaringer fra 1997 og 1998

- Terje P. Hagen, Tor Iversen and Jon Magnussen
- 1999:4: Testing DEA Models of Efficiency in Norwegian Psychiatric Outpatient Clinics

- Sverre Kittelsen and Jon Magnussen
- 1999:3: The importance of micro-data for revaealing income motivated behaviour among GPs

- Tor Iversen and Hilde Lurås
- 1999:2: The interaction between patient shortage and patients waiting time

- Tor Iversen and Hilde Lurås
- 1999:1: Impact of the public/private mix of health insurance on genetic testing

- Michael Hoel and Tor Iversen
| |